A054950 Stock Overview
Develops and sells automation systems and software of dispensing, packaging, and medication management for hospitals and pharmacies worldwide. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 1/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for A054950 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
JVM Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩19,100.00 |
52 Week High | ₩32,800.00 |
52 Week Low | ₩16,970.00 |
Beta | 0.74 |
1 Month Change | 1.22% |
3 Month Change | -7.51% |
1 Year Change | -25.39% |
3 Year Change | 39.93% |
5 Year Change | 32.64% |
Change since IPO | 151.32% |
Recent News & Updates
JVM (KOSDAQ:054950) Is Looking To Continue Growing Its Returns On Capital
Nov 13There's Been No Shortage Of Growth Recently For JVM's (KOSDAQ:054950) Returns On Capital
Jul 22JVM Co., Ltd. (KOSDAQ:054950) Shares Could Be 39% Below Their Intrinsic Value Estimate
Jun 13Recent updates
JVM (KOSDAQ:054950) Is Looking To Continue Growing Its Returns On Capital
Nov 13There's Been No Shortage Of Growth Recently For JVM's (KOSDAQ:054950) Returns On Capital
Jul 22JVM Co., Ltd. (KOSDAQ:054950) Shares Could Be 39% Below Their Intrinsic Value Estimate
Jun 13JVM (KOSDAQ:054950) Seems To Use Debt Rather Sparingly
Apr 13What Is JVM Co., Ltd's (KOSDAQ:054950) Share Price Doing?
Mar 16Is There More Growth In Store For JVM's (KOSDAQ:054950) Returns On Capital?
Mar 03Does JVM's (KOSDAQ:054950) Statutory Profit Adequately Reflect Its Underlying Profit?
Feb 18Here's What You Should Know About JVM Co., Ltd's (KOSDAQ:054950) 1.1% Dividend Yield
Feb 06What Kind Of Investors Own Most Of JVM Co., Ltd (KOSDAQ:054950)?
Jan 25Is JVM (KOSDAQ:054950) Using Too Much Debt?
Jan 13Jvm's (KOSDAQ:054950) Stock Price Has Reduced 34% In The Past Three Years
Jan 01Jvm Co., Ltd's (KOSDAQ:054950) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Dec 20Should You Investigate Jvm Co., Ltd (KOSDAQ:054950) At ₩37,300?
Dec 07What Can The Trends At Jvm (KOSDAQ:054950) Tell Us About Their Returns?
Nov 25Shareholder Returns
A054950 | KR Machinery | KR Market | |
---|---|---|---|
7D | 0.3% | 4.0% | -1.6% |
1Y | -25.4% | 25.0% | -9.1% |
Return vs Industry: A054950 underperformed the KR Machinery industry which returned 21.2% over the past year.
Return vs Market: A054950 underperformed the KR Market which returned -7.7% over the past year.
Price Volatility
A054950 volatility | |
---|---|
A054950 Average Weekly Movement | 6.2% |
Machinery Industry Average Movement | 7.4% |
Market Average Movement | 6.6% |
10% most volatile stocks in KR Market | 12.6% |
10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A054950 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A054950's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1977 | 307 | Dong-hwan Lee | www.myjvm.com |
JVM Co., Ltd. develops and sells automation systems and software of dispensing, packaging, and medication management for hospitals and pharmacies worldwide. It offers automatic dispensing and packaging systems; medication inspection and winding systems; medicine counting systems; canister management systems; automatic tablet counting systems; automatic tablet cutting systems; automatic PTP deblisters; special shape tablets pre-preparation systems; automatic pouch rolling systems; DOB blister paper sealing guides; and automated medication management systems. The company also provides OnCube Management for dispensing, packaging, and medication management; Check VIZEN, a pouch inspection and management software; STS Load Station, an STS pre-packaging software; INTIPharm Management, a medication management software; INTIPharm Notifier, a medication management alert software; INTIPharm Transfer Check, a medication management transfer software; and INTIPharm Secusion Viewer, a medication management image viewer software.
JVM Co., Ltd. Fundamentals Summary
A054950 fundamental statistics | |
---|---|
Market cap | ₩219.99b |
Earnings (TTM) | ₩31.89b |
Revenue (TTM) | ₩159.14b |
6.9x
P/E Ratio1.4x
P/S RatioIs A054950 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A054950 income statement (TTM) | |
---|---|
Revenue | ₩159.14b |
Cost of Revenue | ₩95.36b |
Gross Profit | ₩63.79b |
Other Expenses | ₩31.90b |
Earnings | ₩31.89b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 2.77k |
Gross Margin | 40.08% |
Net Profit Margin | 20.04% |
Debt/Equity Ratio | 15.2% |
How did A054950 perform over the long term?
See historical performance and comparisonDividends
2.1%
Current Dividend Yield14%
Payout RatioDoes A054950 pay a reliable dividends?
See A054950 dividend history and benchmarksJVM dividend dates | |
---|---|
Ex Dividend Date | Dec 27 2024 |
Dividend Pay Date | Apr 09 2025 |
Days until Ex dividend | 7 days |
Days until Dividend pay date | 110 days |
Does A054950 pay a reliable dividends?
See A054950 dividend history and benchmarksCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/19 05:03 |
End of Day Share Price | 2024/12/19 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
JVM Co., Ltd. is covered by 14 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Sae-rom Lee | Daishin Securities Co. Ltd. |
Jong Kyung Choi | DAOL Investment & Securities Co., Ltd. |
Jinhee Kwak | Eugene Investment & Securities Co Ltd. |